TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma

Oshimori, Naoki, Oristian, Daniel, Fuchs, Elaine·2015·Cell

Cited by (472)

Items 101–200 of 472

  1. Tissue clearing to examine tumour complexity in three dimensions
    Jorge Almagro, Hendrik A. Messal, May Zaw Thin, Jacco van Rheenen, Axel Behrens · 2021 · Nature reviews. Cancer
  2. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma
    Toshihiro Sakurai, Kazunobu Isogaya, Satoshi Sakai, Masato Morikawa, Yasuo Morishita, Shogo Ehata, Kohei Miyazono, Daizo Koinuma · 2016 · Oncogene
  3. Targeting cancer stem cells in squamous cell carcinoma
    Demeng Chen, Cun‐Yu Wang · 2019 · Precision Clinical Medicine
  4. Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis
    Erica Dalla, Michael Papanicolaou, Matthew D. Park, Nicole D. Barth, Rui Hou, Deisy Segura-Villalobos, Luis E. Valencia Salazar, Dan Sun, Alistair R. R. Forrest, María Casanova-Acebes et al. · 2024 · Cell
  5. Arginine methylation of SMAD7 by PRMT1 in TGF-β–induced epithelial–mesenchymal transition and epithelial stem-cell generation
    Yoko Katsuno, Jian Qin, Juan A. Osés-Prieto, Hongjun Wang, Olan Jackson‐Weaver, Tingwei Zhang, Samy Lamouille, Jian Wu, Alma L. Burlingame, Jian Xu et al. · 2018 · Journal of Biological Chemistry
  6. MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs
    Lu Wang, Hao Zeng, Qiang Wang, Zibo Zhao, Thomas Boyer, Xiuwu Bian, Wei Xu · 2015 · Science Advances
  7. AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis
    Marie-Anne Goyette, Jean‐François Côté · 2022 · Cancers
  8. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC
    Dan Wang, Yuqiang Li, Heming Ge, Tarik Ghadban, Matthias Reeh, Cenap Güngör · 2022 · Cancers
  9. ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
    Hanseul Yang, Daniel Schramek, Rene C. Adam, Brice E. Keyes, Ping Wang, Deyou Zheng, Elaine V. Fuchs · 2015 · eLife
  10. Targeting invadopodia for blocking breast cancer metastasis
    Tomer Meirson, Hava Gil-Henn · 2018 · Drug Resistance Updates
  11. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas
    Hui-min Lei, Keren Zhang, Cong Hui Wang, Yang Wang, Guanglei Zhuang, Liming Lu, Jian Zhang, Ying H. Shen, Hongzhuan Chen, Liang Zhu · 2019 · Theranostics
  12. Tumour Microenvironment Stress Promotes the Development of Drug Resistance
    Nicole A. Seebacher, Mária Krchniaková, Alexandra E. Stacy, Jan Skoda, Patric J. Jansson · 2021 · Antioxidants
  13. Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment
    Jianping Wu, Yunheng Li, Qiaojun He, Xiaochun Yang · 2023 · Molecules
  14. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy
    Duojiao Wu, Diane C. Wang, Yunfeng Cheng, Mengjia Qian, Miaomiao Zhang, Qi Shen, Xiangdong Wang · 2016 · Seminars in Cancer Biology
  15. Cancer Stemness: p53 at the Wheel
    Dishari Ghatak, Damayanti Das Ghosh, Susanta Roychoudhury · 2021 · Frontiers in Oncology
  16. The Long (lncRNA) and Short (miRNA) of It: TGFβ-Mediated Control of RNA-Binding Proteins and Noncoding RNAs
    Harinarayanan Janakiraman, Reniqua P. House, Vamsi K. Gangaraju, John Alan Diehl, Philip H. Howe, Viswanathan Palanisamy · 2018 · Molecular Cancer Research
  17. Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
    Vittoria Poli, Luca Fagnocchi, Alessio Zippo · 2018 · Stem Cells International
  18. Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma.
    Lucia Raffaella Languino, Amrita Singh, Marco di Prisco, Gareth J. Inman, Adam Luginbuhl, Joseph Curry, Andrew P. South · 2016 · PubMed Central
  19. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway
    Wei‐Min Chang, Yu‐Chan Chang, Yi‐Chieh Yang, Sze-Kwan Lin, Peter Mu‐Hsin Chang, Michael Hsiao · 2019 · Journal of Experimental & Clinical Cancer Research
  20. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy
    Jitang Chen, Zeyang Ding, Si Li, Sha Liu, Chen Xiao, Zifu Li, Bixiang Zhang, Xiaoping Chen, Xiangliang Yang · 2020 · Theranostics
  21. One microenvironment does not fit all: heterogeneity beyond cancer cells
    Ik Sun Kim, Xiang H.-F. Zhang · 2016 · Cancer and Metastasis Reviews
  22. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells
    Fabrizio Marcucci, Pietro Ghezzi, Cristiano Rumio · 2017 · Molecular Cancer
  23. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
    Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano, Jean Calleja‐Agius · 2022 · International Journal of Molecular Sciences
  24. Smad3‐mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial–mesenchymal transition
    Dan Du, Yoko Katsuno, Dominique S. Meyer, Erine H. Budi, Sihan Chen, Hartmut Koeppen, Hongjun Wang, Rosemary J. Akhurst, Rik Derynck · 2017 · EMBO Reports
  25. Hyaluronan‐mediated motility receptor confers resistance to chemotherapy via TGFβ/Smad2‐induced epithelial‐mesenchymal transition in gastric cancer
    Huizhong Zhang, Liangliang Ren, Ya Ding, Feng‐Yan Li, Xiangfu Chen, Ying Ouyang, Yan Zhang, Dongsheng Zhang · 2019 · The FASEB Journal
  26. Hypoxia‐induced HIF‐1α and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF‐β‐dependent EMT
    Shohei Yoshimoto, Fumie Tanaka, Hiromitsu Morita, Akimitsu Hiraki, Shuichi Hashimoto · 2019 · Cancer Medicine
  27. Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer
    Shivkanya Fuloria, Vetriselvan Subramaniyan, Karupiah Sundram, Usha Kumari, Kathiresan V. Sathasivam, Dhanalekshmi Unnikrishnan Meenakshi, Yuan Seng Wu, Mahendran Sekar, Nitin Chitranshi, Rishabha Malviya et al. · 2021 · Antioxidants
  28. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells
    Zhangding Wang, Qiang Wang, Guifang Xu, Na Meng, Xinli Huang, Zerun Jiang, Chen Chen, Yan Zhang, Junjie Chen, Aiping Li et al. · 2019 · RNA Biology
  29. Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
    Laura Jadkauskaite, Pierre A. Coulombe, Matthias Schäfer, Albena T. Dinkova‐Kostova, Ralf Paus, Iain S. Haslam · 2017 · BioEssays
  30. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers
    Haiyan Zhu, Xiang Q. Gu, Lu Xia, You Zhou, Hakim Bouamar, Junhua Yang, Xiaofei Ding, Christian W. Zwieb, Jianan Zhang, Andrew P. Hinck et al. · 2018 · Clinical Cancer Research
  31. TGF‐β receptor I inhibitor enhances response to enzalutamide in a pre‐clinical model of advanced prostate cancer
    Channing Judith Paller, Hong Pu, Diane E. Begemann, Cameron Alexander Wade, Patrick Joseph Hensley, Natasha Kyprianou · 2018 · The Prostate
  32. The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies
    Eric A. Smith, H. Courtney Hodges · 2019 · Trends in cancer
  33. Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities
    Milad Ashrafizadeh, Masoud Najafi, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Negin Sharifi, Kiavash Hushmandi, Ali Zarrabi, Kwang Seok Ahn · 2020 · Biomedicines
  34. BMP signaling: at the gate between activated melanocyte stem cells and differentiation
    Infarinato, Nicole R., Stewart, Katherine S., Yang, Yihao, Gomez, Nicholas C., Pasolli, H. Amalia, Hidalgo, Lynette, Polak, Lisa, Carroll, Thomas S., Fuchs, Elaine · 2020 · Genes & Development
  35. DNA Damage Activates TGF-β Signaling via ATM-c-Cbl-Mediated Stabilization of the Type II Receptor TβRII
    Li, Yuzhen, Liu, Yuan, Chiang, Y. Jeffrey, Huang, Fei, Li, Yehua, Li, Xintong, Ning, Yuanheng, Zhang, Wenhao, Deng, Haiteng, Chen, Ye-Guang · 2019 · Cell Reports
  36. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
    Laura Bornes, Guillaume Belthier, Jacco van Rheenen · 2021 · Journal of Clinical Medicine
  37. Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
    Ana Belén Griso-Acevedo, Lucía Acero-Riaguas, Beatriz Castelo, José Luis Cebrián Carretero, Ana Sastre-Perona · 2022 · Cells
  38. Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21∗ in SCC progression
    Yejing Ge, Liang Zhang, Maria Nikolova, Boris A. Reva, Elaine V. Fuchs · 2015 · Nature Cell Biology
  39. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
    Marta Canel, David Taggart, Andrew H. Sims, David W. Lonergan, Irene C. Waizenegger, Alan Serrels · 2020 · eLife
  40. The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
    Alsina‐Sanchis, Elisenda, Figueras, Agnès, Lahiguera, Álvaro, Vidal, August, Casanovas, Oriol, Graupera, Mariona, Villanueva, Alberto, Viñals, Francesc · 2016 · International Journal of Cancer
  41. TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity
    Shafat Ali, Muneeb U. Rehman, Ali Mohd Yatoo, Azher Mustafa Arafah, Andleeb Khan, Summya Rashid, Sabhiya Majid, Aarif Ali, Md. Niamat Ali · 2023 · European Journal of Pharmacology
  42. Perivascular niches: critical hubs in cancer evolution
    Ada Nowosad, Jean‐Christophe Marine, Panagiotis Karras · 2023 · Trends in cancer
  43. Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes
    Michelle L. Kerns, Jill M. C. Hakim, Rosemary G. Lu, Yajuan Guo, Andreas Berroth, Roger L. Kaspar, Pierre A. Coulombe · 2016 · Journal of Clinical Investigation
  44. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
    Alexandre Teixeira Vessoni, Eduardo Cremonese Filippi‐Chiela, Guido Lenz, Luís F.Z. Batista · 2019 · Oncogene
  45. Stemness in solid malignancies: coping with immune attack
    Judith Agudo, Yuxuan Miao · 2024 · Nature reviews. Cancer
  46. A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells
    Verónica Calvo, Wei Zheng, Anna Adam‐Artigues, Kirk A. Staschke, Xin Huang, Julie F. Cheung, Ana Rita Nobre, Sho Fujisawa, David Liu, Maria Fumagalli et al. · 2023 · Clinical Cancer Research
  47. Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
    Huijun Zeng, Zhao Yang, Ningbo Xu, Boyang Liu, Zhao Fu, Changlin Lian, Hongbo Guo · 2017 · Cell Death and Disease
  48. Partial EMT in Squamous Cell Carcinoma: A Snapshot
    Chengcheng Liao, Qian Wang, Jiaxing An, Qian Long, Hui Wang, Meiling Xiang, Mingli Xiang, Yujie Zhao, Yulin Liu, Jianguo Liu et al. · 2021 · International Journal of Biological Sciences
  49. Deciphering functional tumor states at single‐cell resolution
    Rolando Vegliante, Ievgenia Pastushenko, Cédric Blanpain · 2021 · The EMBO Journal
  50. Matters of context guide future research in TGFβ superfamily signaling
    Akhurst, Rosemary J., Padgett, Richard W. · 2015 · Science Signaling
  51. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma
    Man Wang, Fei Yu, Xinzhe Chen, Peifeng Li, Kun Wang · 2020 · Molecular Therapy — Nucleic Acids
  52. Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma
    Sheng Wu, Xiangkang Lv, Yilin Li, Xinyi Gao, Zhiqi Ma, Xiao Fu, Yong Li · 2022 · Journal of Oncology
  53. Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model
    Liang Yu, Fengyu Zhu, Haojie Zhang, Demeng Chen, Xiuhong Zhang, Qian Gao, Yang Li · 2016 · Scientific Reports
  54. Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
    Zhang, Haiyun, Steed, Alexander, Co, Milo, Chen, Xiaozhuo · 2021 · Cancer Drug Resistance
  55. Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma
    Junhui Sui, Yani Cui, Hanxu Cai, Shaoquan Bian, Zhiyi Xu, Ling Zhou, Yong Sun, Jie Liang, Yujiang Fan, Xingdong Zhang · 2017 · Nanoscale
  56. Reprogramming to developmental plasticity in cancer stem cells
    Caitlin O’Brien‐Ball, Adrian Biddle · 2017 · Developmental Biology
  57. Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
    Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna · 2024 · International Journal of Molecular Sciences
  58. Pancreatic Fibroblast Heterogeneity: From Development to Cancer
    Paloma E. Garcia, Michael K. Scales, Benjamin L. Allen, Marina Pasca di Magliano · 2020 · Cells
  59. Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer
    Pasquale Saggese, Assunta Sellitto, Cesar A. Martinez, Giorgio Giurato, Giovanni Nassa, Francesca Maria Rizzo, Roberta Tarallo, Claudio Scafoglio · 2020 · Cancers
  60. TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells
    Debjani Pal, Anja Pertot, Nitin H. Shirole, Zhan Yao, Naishitha Anaparthy, Tyler H. Garvin, Hilary Cox, Kenneth Chang, Fred Rollins, Jude Kendall et al. · 2017 · eLife
  61. Localized multidrug co-delivery by injectable self-crosslinking hydrogel for synergistic combinational chemotherapy
    Mengmeng He, Junhui Sui, Yafang Chen, Shaoquan Bian, Yani Cui, Changchun Zhou, Yong Sun, Jie Liang, Yujiang Fan, Xingdong Zhang · 2017 · Journal of Materials Chemistry B
  62. TGF-β mediated drug resistance in solid cancer
    Marta Turati, Alexandra Mousset, Nervana Issa, Andrei Turtoï, Roberto Ronca · 2023 · Cytokine & Growth Factor Reviews
  63. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
    Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, Siavash Seifollahy Fakhr, Fatemeh Jafari Baei, Fereshteh Faghih Khorasani, Mohammad Mehdi Zare, Nazanin Pazhouhesh Far, Fatemeh Rezaei‐Tazangi, Jun Tao Ren et al. · 2024 · Cancer and Metastasis Reviews
  64. Keratoacanthoma: a distinct entity?
    Tobias Gleich, Elena Chiticariu, Marcel Huber, Daniel Hohl · 2015 · Experimental Dermatology
  65. Targeting Cancer Cell Metastasis by Converting Cancer Cells into Fat
    Dana Ishay-Ronen, Gerhard Christofori · 2019 · Cancer Research
  66. A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma
    Jee-Eun Choi, Carlos Sebastián, Christina M. Ferrer, Caroline A. Lewis, Moshe Sade-Feldman, Thomas James LaSalle, Anna L. K. Gonye, Begona G. C. Lopez, Walid M. Abdelmoula, Michael Scott Regan et al. · 2021 · Nature Metabolism
  67. An emerging role for cellular crosstalk in the cancer stem cell niche
    Naoki Oshimori, Yifei Guo, Sachiko Taniguchi · 2021 · The Journal of Pathology
  68. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy
    Song Shen, Chunyang Sun, Xiao‐Jiao Du, Hongjun Li, Yang Liu, Jinxing Xia, Yanhua Zhu, Jun Wang · 2015 · Biomaterials
  69. CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development
    Carine Ervolino de Oliveira, Thaís Helena Gasparoto, Cláudia Ramos Pinheiro, Nádia Ghinelli Amôr, Maria Renata Sales Nogueira, Ramon Kaneno, Gustavo Pompermaier Garlet, Vanessa Soares Lara, João S. Silva, Karen Angelica Cavassani et al. · 2017 · Molecular Cancer Therapeutics
  70. Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
    Kieren D. Marini, David R. Croucher, Rachael A. McCloy, Vijesh Vaghjiani, Álvaro González-Rajal, Jordan F. Hastings, Venessa T. Chin, Anette Szczepny, Kaja Kostyrko, César P. Márquez et al. · 2018 · Science Translational Medicine
  71. JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
    Karmveer Singh, Emanuela Camera, Linda Krug, Abhijit Basu, Rajeev Pandey, Saira Munir, Meinhard Wlaschek, Stefan Kochanek, Marina Schorpp‐Kistner, Mauro Picardo et al. · 2018 · Nature Communications
  72. Emerging targets in cancer drug resistance
    Shashank Kumar, Prem Prakash Kushwaha, Sanjay Gupta · 2019 · Cancer Drug Resistance
  73. Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells
    Qikai Sun, Zechuan Zhang, Yijun Lu, Qiaoyu Liu, Xiaoliang Xu, Jianbo Xu, Yang Liu, Hailong Yu, Decai Yu, Beicheng Sun · 2019 · Hepatology
  74. miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma
    Shukai Yuan, Peitao Zhang, Liqi Wen, Shikai Jia, Yufan Wu, Zhenlei Zhang, Lizhao Guan, Zhengquan Yu, Li Zhao · 2021 · Oncogene
  75. Homeostasis, regeneration and tumour formation in the mammalian epidermis
    Daria Belokhvostova, Ieva Berzanskyte, Ana-Maria Cujba, Geraldine M. Jowett, Lucy Marshall, Johanna Prüller, Fiona M. Watt · 2018 · The International Journal of Developmental Biology
  76. Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors
    Maria Serena Roca, Elena Di Gennaro, Alfredo Budillon · 2019 · Journal of Clinical Medicine
  77. Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer
    Lu Yang, Ning Li, Zhicheng Xue, Ling-Rui Liu, Jian Li, Xiaojia Huang, Xinhua Xie, Yutian Zou, Hailin Tang, Xiaoming Xie · 2020 · Cell Death and Differentiation
  78. USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2
    Ning Dou, Qingqing Hu, Li Li, Qiong Wu, Yandong Li, Yong Gao · 2020 · International Journal of Biological Sciences
  79. TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells
    Nathan Ungerleider, Chang Han, Jinqiang Zhang, Lu Yao, Tong Wu · 2016 · Molecular Carcinogenesis
  80. Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
    Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar · 2023 · Cancers
  81. Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer
    Lingyan Wang, Bijun Zhu, Miaomiao Zhang, Xiangdong Wang · 2016 · Seminars in Cell and Developmental Biology
  82. Tumor microenvironment diversity and plasticity in cancer multidrug resistance
    Zhi Li, Peihao Yin · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  83. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer
    Yang Zhang, Yi Zhang, Liying Geng, Haowei Yi, Wei Huo, Geoffrey A. Talmon, Yeong C. Kim, San Ming Wang, Jing Wang · 2016 · Journal of Biological Chemistry · Retracted
  84. Myxofibrosarcoma primary cultures: molecular and pharmacological profile
    Alessandro De Vita, Federica Recine, Laura Mercatali, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Roberto Casadei, Alberto Bongiovanni, Federica Pieri, Nada Riva et al. · 2017 · Therapeutic Advances in Medical Oncology
  85. Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma
    Pierre-Antoine Bissey, Jacqueline H. Law, Jeff P. Bruce, Wei Shi, Aline Renoult, Melvin L.K. Chua, Kenneth W. Yip, Fei‐Fei Liu · 2018 · Oncogenesis
  86. Cellular Barcoding Identifies Clonal Substitution as a Hallmark of Local Recurrence in a Surgical Model of Head and Neck Squamous Cell Carcinoma
    Vincent Roh, Pierre Abramowski, Agnès Hiou‐Feige, Kerstin Cornils, J.P. Rivals, Alexandre Zougman, Tim Aranyossy, Lars Thielecke, Zinnia Truan, Maxime Mermod et al. · 2018 · Cell Reports
  87. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment
    Derek W. Edwardson, Amadeo Mark Parissenti, A. Thomas Kovala · 2019 · Advances in experimental medicine and biology
  88. Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated
    Keywan Mortezaee, Jamal Majidpoor, Ebrahim Kharazinejad · 2022 · Medical Oncology
  89. Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
    Max Kam‐Kwan Chan, Emily Lok-Yiu Chan, Zoey Zeyuan Ji, Alex Siu Wing Chan, Chunjie Li, Kam Tong Leung, Ka‐Fai To, Patrick Ming‐Kuen Tang · 2023 · Exploration of Targeted Anti-tumor Therapy
  90. Molecular Biology of Basal and Squamous Cell Carcinomas
    Steffen Emmert, Michael Peter Schön, Holger Andreas Haenssle · 2014 · Springer eBooks
  91. Calreticulin is highly expressed in pancreatic cancer stem‐like cells
    Satoshi Matsukuma, Kiyoshi Yoshimura, Tomio Ueno, Atsunori Oga, Moeko Inoue, Yusaku Watanabe, Atsuo Kuramasu, Masanori Fuse, Ryouichi Tsunedomi, Satoshi Nagaoka et al. · 2016 · Cancer Science
  92. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling
    Yijun Qi, Ye-Lin Jiao, Pan Chen, Jinyu Kong, Bianli Gu, Ke Liu, Dan-Dan Feng, Ya-Fei Zhu, Hao-Jie Ruan, Zijun Lan et al. · 2020 · PLoS Biology · Retracted
  93. Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
    Steffanus Pranoto Hallis, Jin Myung Kim, Mi‐Kyoung Kwak · 2023 · Molecules and Cells
  94. Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
    Beatriz Bueschbell, Ana B. Caniceiro, Pedro M. S. Suzano, Miguel Machuqueiro, Nícia Rosário‐Ferreira, Irina Sousa Moreira · 2022 · Drug Resistance Updates
  95. Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules
    Kazuhito Naka, Atsushi Hirao · 2017 · Cold Spring Harbor Perspectives in Biology
  96. Targeting cancer drug resistance utilizing organoid technology
    Changpeng Chai, Pengfei Ji, Hao Xu, Huan Tang, Zhengfeng Wang, Hui Zhang, Wence Zhou · 2022 · Biomedicine & Pharmacotherapy
  97. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma
    Satoru Shinriki, Hirofumi Jono, Manabu Maeshiro, Takuya Nakamura, Jianying Guo, Jiandong Li, Mitsuharu Ueda, Ryoji Yoshida, Masanori Shinohara, Hideki Nakayama et al. · 2017 · The Journal of Pathology
  98. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
    Pierre-Antoine Bissey, Mona Teng, Jacqueline H. Law, Wei Shi, Jeff P. Bruce, Valentin Petit, Sai Wah Tsao, Kenneth W. Yip, Fei‐Fei Liu · 2020 · BMC Cancer
  99. Cancer stem cells and their niche in the progression of squamous cell carcinoma
    Naoki Oshimori · 2020 · Cancer Science
  100. Engaging plasticity: Differentiation therapy in solid tumors
    Bar-Hai, Neta, Ishay-Ronen, Dana · 2022 · Frontiers in Pharmacology